Horizon appoints CBO

Robert F. Carey has been appointed executive vice president and chief business officer at Horizon Pharma, Inc. Mr. Carey brings extensive healthcare investment banking experience having assisted biotech and specialty pharma companies raise more than $10 billion in initial public offerings, follow-on offerings, debt offerings and private placements. He has also served as a financial advisor on mergers, acquisitions and strategic alliances.
 
Mr. Carey joins the company from JMP Securities LLC, where spent more than 11 years as managing director and head of the life sciences investment banking group. Prior to JMP, Mr. Carey was a managing director in the healthcare groups at Dresdner Kleinwort Wasserstein and Vector Securities, and held roles at Red Hen Bread, InStadium, Shearson Lehman Hutton and Ernst & Whinney.
 
“Bob’s tremendous industry and deal-making experience will be invaluable to us as we look to expand our business through acquisitions of products and companies,” said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma. “With our focus on acquiring additional innovative medicines or companies that complement our products and leverage our commercial infrastructure, Bob is a key addition to our executive team.”